NECO, MCPHS explore joining forces

Article

New England College of Optometry (NECO) and Massachusetts College of Pharmacy and Health Sciences (MCPHS) consider joining forces.

 

Boston-New England College of Optometry (NECO) and Massachusetts College of Pharmacy and Health Sciences (MCPHS) have signed a letter of intent to explore a potential combination.

Officials from both colleges said a natural synergy exists between the institutions to support combining the two schools. The officials also said such a move would create an opportunity to expand NECO’s highly respected brand and expertise in optometry to Worcester.

Steven Manfredi, NECO’s board chairman said, “We are confident that our focus on a high-quality optometry educational experience will be affirmed and that there will be continuity for current students, faculty, and staff.”

Charles F. Monahan, Jr., MCPHS president, said, “We see a bright and growing future for NECO and the continuation of its position as a leader in optometric education, and an opportunity for MCPHS University to continue to expand its depth and breadth in global health care education.”

NECO’s campus is located in Boston’s Back Bay neighborhood. The college provides a 4-year post-baccalaureate curriculum in optometry to about 475 students. MCPHS has campuses in Boston and Worcester, MA, and Manchester, NH. More than 6,000 undergraduate and graduate students are pursuing degrees in approximately 50 academic programs, including optometry, on MCPHS’s three campuses. MCPHS founded its School of Optometry on its Worcester campus on 2011.

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.